353 related articles for article (PubMed ID: 16322085)
21. Trends in antirheumatic medication use among patients with rheumatoid arthritis, 1981-1996.
Ward MM; Fries JF
J Rheumatol; 1998 Mar; 25(3):408-16. PubMed ID: 9517756
[TBL] [Abstract][Full Text] [Related]
22. Advance and unmet need of health care for patients with rheumatoid arthritis in the German population--results from the German Rheumatoid Arthritis Population Survey (GRAPS).
Westhoff G; Schneider M; Raspe H; Zeidler H; Runge C; Volmer T; Zink A
Rheumatology (Oxford); 2009 Jun; 48(6):650-7. PubMed ID: 19321515
[TBL] [Abstract][Full Text] [Related]
23. Predictors of response to anti-TNF-alpha therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register.
Hyrich KL; Watson KD; Silman AJ; Symmons DP;
Rheumatology (Oxford); 2006 Dec; 45(12):1558-65. PubMed ID: 16705046
[TBL] [Abstract][Full Text] [Related]
24. The use of disease modifying antirheumatic drugs in women with rheumatoid arthritis of childbearing age: a survey of practice patterns and pregnancy outcomes.
Chakravarty EF; Sanchez-Yamamoto D; Bush TM
J Rheumatol; 2003 Feb; 30(2):241-6. PubMed ID: 12563675
[TBL] [Abstract][Full Text] [Related]
25. Patient decision-making related to antirheumatic drugs in rheumatoid arthritis: the importance of patient trust of physician.
Martin RW; Head AJ; René J; Swartz TJ; Fiechtner JJ; McIntosh BA; Holmes-Rovner M
J Rheumatol; 2008 Apr; 35(4):618-24. PubMed ID: 18278840
[TBL] [Abstract][Full Text] [Related]
26. Real-world utilization of DMARDs and biologics in rheumatoid arthritis: the RADIUS (Rheumatoid Arthritis Disease-Modifying Anti-Rheumatic Drug Intervention and Utilization Study) study.
Gibofsky A; Palmer WR; Goldman JA; Lautzenheiser RL; Markenson JA; Weaver A; Schiff MH; Keystone EC; Paulus HE; Harrison MJ; Whitmore JB; Leff JA
Curr Med Res Opin; 2006 Jan; 22(1):169-83. PubMed ID: 16393443
[TBL] [Abstract][Full Text] [Related]
27. Effectiveness of systematic monitoring of rheumatoid arthritis disease activity in daily practice: a multicentre, cluster randomised controlled trial.
Fransen J; Moens HB; Speyer I; van Riel PL
Ann Rheum Dis; 2005 Sep; 64(9):1294-8. PubMed ID: 15829574
[TBL] [Abstract][Full Text] [Related]
28. Utilization trends of tumor necrosis factor inhibitors among patients with rheumatoid arthritis in a United States observational cohort study.
Lee SJ; Chang H; Yazici Y; Greenberg JD; Kremer JM; Kavanaugh A
J Rheumatol; 2009 Aug; 36(8):1611-7. PubMed ID: 19369454
[TBL] [Abstract][Full Text] [Related]
29. Differences in the use of second-line agents and prednisone for treatment of rheumatoid arthritis by rheumatologists and non-rheumatologists.
Criswell LA; Such CL; Yelin EH
J Rheumatol; 1997 Dec; 24(12):2283-90. PubMed ID: 9415629
[TBL] [Abstract][Full Text] [Related]
30. Most rheumatologists are conservative in active rheumatoid arthritis despite methotrexate therapy: results of the PRISME survey.
Saraux A; Devauchelle-Pensec V; Engerran L; Flipo RM
J Rheumatol; 2006 Jul; 33(7):1258-65. PubMed ID: 16783865
[TBL] [Abstract][Full Text] [Related]
31. Characteristics of patients with rheumatoid arthritis in France: a study of 1109 patients managed by hospital based rheumatologists.
Sany J; Bourgeois P; Saraux A; Durieux S; Lafuma A; Daurès JP; Guillemin F; Sibilia J
Ann Rheum Dis; 2004 Oct; 63(10):1235-40. PubMed ID: 15361378
[TBL] [Abstract][Full Text] [Related]
32. Use of second line drugs for the treatment of rheumatoid arthritis in Edmonton, Alberta. Patterns of prescription and longterm effectiveness.
Suarez-Almazor ME; Soskolne CL; Saunders LD; Russell AS
J Rheumatol; 1995 May; 22(5):836-43. PubMed ID: 8587069
[TBL] [Abstract][Full Text] [Related]
33. Response-driven combination therapy with conventional disease-modifying antirheumatic drugs can achieve high response rates in early rheumatoid arthritis with minimal glucocorticoid and nonsteroidal anti-inflammatory drug use.
Proudman SM; Keen HI; Stamp LK; Lee AT; Goldblatt F; Ayres OC; Rischmueller M; James MJ; Hill CL; Caughey GE; Cleland LG
Semin Arthritis Rheum; 2007 Oct; 37(2):99-111. PubMed ID: 17391739
[TBL] [Abstract][Full Text] [Related]
34. Common polymorphisms in the folate pathway predict efficacy of combination regimens containing methotrexate and sulfasalazine in early rheumatoid arthritis.
James HM; Gillis D; Hissaria P; Lester S; Somogyi AA; Cleland LG; Proudman SM
J Rheumatol; 2008 Apr; 35(4):562-71. PubMed ID: 18322994
[TBL] [Abstract][Full Text] [Related]
35. Triple therapy in early active rheumatoid arthritis: a randomized, single-blind, controlled trial comparing step-up and parallel treatment strategies.
Saunders SA; Capell HA; Stirling A; Vallance R; Kincaid W; McMahon AD; Porter DR
Arthritis Rheum; 2008 May; 58(5):1310-7. PubMed ID: 18438851
[TBL] [Abstract][Full Text] [Related]
36. Tumor necrosis factor alpha antagonist use and cancer in patients with rheumatoid arthritis.
Setoguchi S; Solomon DH; Weinblatt ME; Katz JN; Avorn J; Glynn RJ; Cook EF; Carney G; Schneeweiss S
Arthritis Rheum; 2006 Sep; 54(9):2757-64. PubMed ID: 16947774
[TBL] [Abstract][Full Text] [Related]
37. Providing patients with information about disease-modifying anti-rheumatic drugs: Individually or in groups? A pilot randomized controlled trial comparing adherence and satisfaction.
Homer D; Nightingale P; Jobanputra P
Musculoskeletal Care; 2009 Jun; 7(2):78-92. PubMed ID: 18792423
[TBL] [Abstract][Full Text] [Related]
38. What explains the variation among rheumatologists in their use of prednisone and second line agents for the treatment of rheumatoid arthritis?
Criswell LA; Henke CJ
J Rheumatol; 1995 May; 22(5):829-35. PubMed ID: 8587068
[TBL] [Abstract][Full Text] [Related]
39. Initiation of disease-modifying antirheumatic drug therapy in minority and disadvantaged patients with rheumatoid arthritis.
Suarez-Almazor ME; Berrios-Rivera JP; Cox V; Janssen NM; Marcus DM; Sessoms S
J Rheumatol; 2007 Dec; 34(12):2400-7. PubMed ID: 17985405
[TBL] [Abstract][Full Text] [Related]
40. Disease-modifying antirheumatic drugs are associated with a reduced risk for cardiovascular disease in patients with rheumatoid arthritis: a case control study.
van Halm VP; Nurmohamed MT; Twisk JW; Dijkmans BA; Voskuyl AE
Arthritis Res Ther; 2006; 8(5):R151. PubMed ID: 16984661
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
